Jumpei Kashima
-
- Lung Cancer Treatments and Mutations 21
- Lung Cancer Diagnosis and Treatment 7
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 3
- Medical Imaging and Pathology Studies 3
- Oncology top 10%
- Lung Cancer Research Studies 11
- Cancer Immunotherapy and Biomarkers 9
-
- Myasthenia Gravis and Thymoma 5
- Neuroblastoma Research and Treatments 3
Jumpei Kashima
39 papers receiving 564 citations
Peers
Comparison fields: 5 of 61
- Pulmonary and Respiratory Medicine 311
- Oncology 233
- Microbiology 5
- Radiology, Nuclear Medicine and Imaging 114
- Hepatology 31
Countries citing papers authored by Jumpei Kashima
This map shows the geographic impact of Jumpei Kashima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jumpei Kashima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jumpei Kashima more than expected).
Fields of papers citing papers by Jumpei Kashima
This network shows the impact of papers produced by Jumpei Kashima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jumpei Kashima. The network helps show where Jumpei Kashima may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jumpei Kashima, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 4 | |
| 4 | 2023 | 4 | |
| 5 | 2022 | 67 | |
| 6 | 2022 | 6 | |
| 7 | 2022 | 10 | |
| 8 | 2022 | 7 | |
| 9 | 2021 | 1 | |
| 10 | 2021 | 25 | |
| 11 | 2021 | 1 | |
| 12 | 2021 | 12 | |
| 13 | 2021 | 101 | |
| 14 | 2020 | 18 | |
| 15 | 2019 | 12 | |
| 16 | 2019 | 1 | |
| 17 | 2018 | 19 | |
| 18 | 2017 | 8 | |
| 19 | 2016 | 15 | |
| 20 | 2016 | 8 |
About Jumpei Kashima
Jumpei Kashima is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Neurology, having authored 41 papers that have together received 566 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (21 papers), Lung Cancer Research Studies (11 papers), Cancer Immunotherapy and Biomarkers (9 papers), Lung Cancer Diagnosis and Treatment (7 papers), Myasthenia Gravis and Thymoma (5 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers), Neuroblastoma Research and Treatments (3 papers) and Medical Imaging and Pathology Studies (3 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (311 citations), Oncology (233 citations) and Microbiology (5 citations). Jumpei Kashima has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Yusuke Okuma, Yasushi Yatabe, Yukihiro Yoshida, Tsunekazu Hishima, Yukio Hosomi, Kazuro Chiba, Rui Kitadai, Masaya Yotsukura, Kazuo Nakagawa and Shun‐ichi Watanabe. Their work appears in journals such as Journal of Thoracic Oncology, OncoTargets and Therapy, Histopathology, Lung Cancer and Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.